Skip to content
Screener

CareDx CDNA Reportable Segment — Stock-based compensation expense

Similar metrics at other companies

Butterfly Network logo
BFLYReportable segment — Stock-based compensation expense
$6.89M+17.5%
Backblaze, Inc. logo
BLZEReportable Segment — Stock-based compensation expense
$6.71M-8.8%
Twist Bioscience Corporation logo
TWSTReportable Segment — Stock-based compensation expense
$18.94M-6.8%
Accel Entertainment logo
ACELReportable Segment — Stock-based compensation expense
$2.5M+19.5%
Riley Exploration Permian logo
REPXReportable Segment — Stock-based compensation expense
$3.92M+45.9%
Grindr logo
GRNDReportable Segment — Stock-based compensation expense
$20.63M+24.8%

Other financials

Income statement

See full
Revenue$117.7M+39.0%
Operating income$1.2M+109%
Net income$2.8M+127%
EPS (diluted)$0.05+126%

Balance sheet

See full
Cash & equivalents$78.5M-12.1%
Total debt$24.5M-19.1%
Total equity$313.5M-17.3%
Total assets$411.1M-16.0%

Cash flow

See full
Operating cash flow$4.3M+116%
CapEx$3.8M+134%
Free cash flow$514.0K+102%

Valuation

See full
Market cap$2.42B+279%
Enterprise value$2.36B+295%
P/S5.9×+4.0×

Profitability

See full
Gross margin65.5%
Operating margin-3.9%-18.3pp
Net margin-2%-19.9pp
FCF margin-0%0.0pp

Returns & leverage

See full
Return on equity-2.4%-21.9pp
Debt / equity0.1×0.0×
Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:AllocatedShareBasedCompensationExpense.

The source filing: CareDx’s 10-Q, filed April 28, 2026.

Filed
Apr 28, 2026, 4:13 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001217234-26-000033
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Professional and legal fees7,91210,192
Research materials and clinical trials expense3,8313,174
Depreciation and amortization expense3,1192,950
Stock-based compensation expense9,7678,931
Litigation settlement expense6005,360
Business development and portfolio optimization expense23,357
Other segment items313,8609,781
Interest income, net(1,909)(2,783)

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is CareDx's reportable segment — stock-based compensation expense?
CareDx (CDNA) reported reportable segment — stock-based compensation expense of $9.77M in Q1 2026.
How has CareDx's reportable segment — stock-based compensation expense changed year-over-year?
CareDx's reportable segment — stock-based compensation expense increased by 9.4% year-over-year, from $8.93M to $9.77M.
What is the long-term trend for CareDx's reportable segment — stock-based compensation expense?
Over 3 years (2022 to 2025), CareDx's reportable segment — stock-based compensation expense has grown at a -9.2% compound annual growth rate (CAGR), from $46.55M to $34.86M.
What does reportable segment — stock-based compensation expense mean?
Reflects the non-cash expense recognized for equity-based awards granted to employees and management within the segment. This metric is critical for evaluating the true cost of human capital and the alignment of management incentives with shareholder interests.

Ask your AI about CareDx's reportable segment — stock-based compensation expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude